Institution profile

表参道総合医療クリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01C2407093 +8

Location

Prefecture
Tokyo
Address
渋谷区神宮前5丁目46-16 イル・チェントロ・セレーノ1階

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • SCSF再生医療等委員会
  • 同仁会認定再生医療等委員会

Public score

71.3/ 100

A · Review level
25.0 / 30
B · Technologies
26.5 / 35
C · Coverage
10.7 / 25
D · Class I / II technologies
9.2 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 71.3
Public score →100

Registered technologies (9)

Stem cells (all sources) 8
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた関節疾患の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自己脂肪由来幹細胞を用いた神経後遺症の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた脳卒中後遺症の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた頚椎症・腰椎症の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いたパーキンソン病の治療(静脈投与)Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いたパーキンソン病の治療(局所投与)Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた認知症性疾患の治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 8
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた慢性疼痛の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた関節疾患の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自己脂肪由来幹細胞を用いた神経後遺症の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた脳卒中後遺症の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた頚椎症・腰椎症の治療Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いたパーキンソン病の治療(静脈投与)Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いたパーキンソン病の治療(局所投与)Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いた認知症性疾患の治療Stem cells (all sources)Adipose-derived stem cellsClass II
NK and immune cells 1
Registered technologies · Japanese originalTechnology areasPlan classification
複合免疫療法(がんの治療、予防および免疫力改善を期待する複合型免疫細胞療法)NK and immune cellsClass III
Joints and musculoskeletal 1
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来幹細胞を用いた関節疾患の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • SCSF再生医療等委員会
  • 同仁会認定再生医療等委員会

Public document number

  • 01C2407093
  • 01C2407094
  • 01C2506023
  • 02C2507069
  • 02C2507070
  • 01C2604018
  • 01C2604019
  • 01C2604020
  • 02C2409024
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自己脂肪由来幹細胞を用いた脳卒中後遺症の治療Class IIJSCSF再生医療等委員会01C2407093
自己脂肪由来幹細胞を用いた頚椎症・腰椎症の治療Class IISCSF再生医療等委員会01C2407094
自己脂肪由来幹細胞を用いた関節疾患の治療Class IIJSCSF再生医療等委員会01C2506023
自己脂肪由来幹細胞を用いた慢性疼痛の治療Class IIJSCSF再生医療等委員会02C2507069
自己脂肪由来幹細胞を用いた神経後遺症の治療Class IIJSCSF再生医療等委員会02C2507070
自己脂肪由来幹細胞を用いたパーキンソン病の治療(静脈投与)Class IIJSCSF再生医療等委員会01C2604018
自己脂肪由来幹細胞を用いたパーキンソン病の治療(局所投与)Class IIJSCSF再生医療等委員会01C2604019
自己脂肪由来幹細胞を用いた認知症性疾患の治療Class IIJSCSF再生医療等委員会01C2604020
複合免疫療法(がんの治療、予防および免疫力改善を期待する複合型免疫細胞療法)Class III同仁会認定再生医療等委員会02C2409024

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor